Background Gregory Fischer Julie Anderson Daniel Herman  Department of Biology  University of Wisconsin-Eau Claire Heterologous expression of MBP1 from.

Slides:



Advertisements
Similar presentations
Section H Cloning Vectors
Advertisements

Abstract Background Gregory Fischer, Julie Anderson, Daniel Herman  Department of Biology  University of Wisconsin-Eau Claire The yeast species Candida.
Elucidating the role of MBP1 in the pathogenesis of Candida albicans Gregory J. Fischer Julie Anderson Daniel Herman Department of Biology University of.
Dolly the sheep ( ) 1. Animal and human cloning 2. Gene cloning.
Chapter 4: recombinant DNA
Detecting Proteins that Interact with the Mbp1 Protein Using Yeast Two-Hybrid Analysis Josh McHugh Faculty Mentor: Dr. Dan Herman University of Wisconsin.
The Role of the Ypd1 Protein in Morphogenesis in Candida albicans Megan Lindner and Dr. Daniel Herman, Research Advisor University of Wisconsin-Eau Claire.
PRESENTED BY: LAUREN SHIN MENTOR: DR. LUIZ BERMUDEZ MICROBIOLOGY DEPARTMENT Determining the Role of the luxR homolog in Mycobacterium avium subsp. paratuberculosis.
Molecular Cloning Biology 20L Spring Overview of Molecular Cloning Restriction digest of plasmid pUC19 and phage –GOAL: Linear pUC19 DNA and several.
MCB 130L Lecture 1: DNA.
MCB 130L Lecture 1 1. How to get the most from your time in lab 2. Recombinant DNA 3. Tips on giving a Powerpoint talk.
Making, screening and analyzing cDNA clones Genomic DNA clones
Plasmid purification lab
The Role of Candida albicans MBP1 in Yeast Pathogenesis Aric Runzheimer Cody Fisher Dr. Julie Anderson Department of Biology University of Wisconsin–Eau.
Goal: To identify yeast gene products important for accurate chromosome transmission in mitosis. Importance: Errors during chromosome transmission in humans.
Analysis of Transgenic Plants. 1.Regeneration on Selective Medium Selectable Marker Gene.
DNA Technology and Genomics
20.1 – 1 Look at the illustration of “Cloning a Human Gene in a Bacterial Plasmid” (Figure 20.4 in the orange book). If the medium used for plating cells.
DNA Technology- Cloning, Libraries, and PCR 17 November, 2003 Text Chapter 20.
Objective 2: TSWBAT describe the basic process of genetic engineering and the applications of it.
Kristin Rosche, Emily Thornsen & Lloyd Turtinen  Department of Biology  University of Wisconsin-Eau Claire Knockout of the US29 gene of Human Cytomegalovirus.
Manufacture of Human Interleukin 13 Protein Using a Prokaryotic Expression System Ryan Rupp, York College of Pennsylvania, Department of Biological Sciences.
Trends in Biotechnology
-The methods section of the course covers chapters 21 and 22, not chapters 20 and 21 -Paper discussion on Tuesday - assignment due at the start of class.
20.1 – 1 Look at the illustration of “Cloning a Human Gene in a Bacterial Plasmid” (Figure 20.4 in the orange book). If the medium used for plating cells.
Using mutants to clone genes Objectives 1. What is positional cloning? 2.What is insertional tagging? 3.How can one confirm that the gene cloned is the.
1 Genetics Faculty of Agriculture Instructor: Dr. Jihad Abdallah Topic 13:Recombinant DNA Technology.
Localization of the C. albicans MBP1 Gene Product in S. cerevisiae Aric Runzheimer Dr. Julie Anderson Department of Biology University of Wisconsin–Eau.
Recombinant DNA I Basics of molecular cloning Polymerase chain reaction cDNA clones and screening.
Today: Biotechnology. Over 600 recent transposon insertions were identified by examining DNA from 36 genetically diverse humans. Tbl 1 Which transposable.
Fluidity of the 16S rRNA Gene Sequence within Aeromonas Strains Alessia Morandi Institute for Infectious Diseases University of Berne.
Cloning Vectors Section H H1 Design of plasmid vectors H2 Bacteriophage vectors H3 Cosmids H4 YAC H5 Eukaryotic vectors.
Genetic Engineering An Overview. What is it??? Applied techniques of genetics and biotechnology (“Wet lab procedure”). Much trial and error. Applied techniques.
DNA TECHNOLOGY AND GENOMICS CHAPTER 20 P
-Know that we can manipulate genomes by inserting or deleting certain genes. -What about synthesizing an entirely novel genome using sequencing technology?
LOGO Isolation and characterization of regulators of oxidative stress induced apoptosis in yeast Yaron Fireizen, Christine Crozier and Julie Anderson Biology.
Biotechnology Chapter 17.
Expression of Deer Adenovirus Spike Protein By: Dang Duong.
Chapter 20: DNA Technology and Genomics - Lots of different techniques - Many used in combination with each other - Uses information from every chapter.
Molecular Biology II Lecture 1 OrR. Restriction Endonuclease (sticky end)
Molecular Cloning.
DNA Technology Ch. 20. The Human Genome The human genome has over 3 billion base pairs 97% does not code for proteins Called “Junk DNA” or “Noncoding.
Plasmid Isolation Prepared by Latifa Aljebali Office: Building 5, 3 rd floor, 5T250.
MOLECULAR BIOLOGY IN ACTION In this project, students will use what they have learned in the previous courses to complete a larger multi-step molecular.
BIO 208 NUCLEIC ACID METHODS Stephanie Schumaker.
Plan A Topics? 1.Making a probiotic strain of E.coli that destroys oxalate to help treat kidney stones in collaboration with Dr. Lucent and Dr. VanWert.
Molecular Cloning. Definitions   Cloning :   Obtaining a piece of DNA from its original source (Genome) and introducing it in a DNA vector   Sub-cloning:
The Importance of Mitochondrial Morphology in Saccharomyces cerevisiae NSF EPSCoR Mentor: Dr. Peter Thorsness Molecular Biology Dept University of Wyoming.
DNA Isolation. Nucleic Acid Structure & Function DNA & RNA are composed of Nucleotides A nucleotide consists of three covalently-linked parts: –A nitrogen.
- making changes to the DNA code of a living organism.
E.Coli AS MODERN VECTOR.
2470 bp 1891 bp WT bp 2314 bp A B Fig. S1. Verification with PCR amplification of the.
DNA Technology and Genomics
Biotechnology and Recombinant DNA
Biotechnology and Recombinant DNA
Cloning Overview DNA can be cloned into bacterial plasmids for research or commercial applications. The recombinant plasmids can be used as a source of.
Today: Biotechnology Exam #2 Th 10/23 in class.
Chapter 20: DNA Technology and Genomics
Biotech Tools Review
Vav‐1 gene‐targeting strategy.
RESULTS AND DISCUSSION
Biotechnology and Recombinant DNA
TOOLS OF BIOTECHNOLOGY
Nonfilamentous C. albicans Mutants Are Avirulent
Volume 4, Issue 3, Pages (May 2011)
Chapter 20: DNA Technology and Genomics
GENE TECHNOLOGY Chapter 13.
E.Coli AS MODERN VECTOR.
Presentation transcript:

Background Gregory Fischer Julie Anderson Daniel Herman  Department of Biology  University of Wisconsin-Eau Claire Heterologous expression of MBP1 from C. albicans in S. cerevisiae: A nontraditional approach Heterologous expression of MBP1 from C. albicans in S. cerevisiae: A nontraditional approach MBP1 Toxicity in Bacteria  Restriction mapping to verify the integrity of the MBP1 insert confirmed the sequence was maintained before transformation into bacteria (Figure 5).  Post-transformation digests of extracted plasmid found that sequence fidelity was lost. Enzymatic digest of transformant plasmid was unsuccessful due to loss of restriction sites in and around the insert site (Figure 6).  MBP1 was digested into two fragments (1.6 kb and 900 bp), ligated into the pESC vectors, and transformed into bacteria. Results confirmed DNA integrity was maintained (Figure 7).  Therefore, full-length MBP1 seems to be toxic to bacteria. This faculty/student research collaboration was made possible through Differential Tuition and a generous grant from the Office of Research and Sponsored Programs. Detecting MBP1 Construct via PCR Future Work Direction of DNA Synthesis 3’ 5’ PGAL10 MCS1 GAL10R Primer 5’ 3’ PGAL1 MCS2 5’ GAL1R Primer 5’ 3’ PGAL1 MCS2 3’ 5’ MCS1 PGAL10 MBP1 Insert (2.5 kb) 1. Denaturation of Template 2. Primer Annealing 3. DNA Synthesis By preferentially amplifying a specific region of the vector, the PCR product will confirm if the plasmid was extracted and whether the MBP1 insert is present. 1,000 bp region LeuUra MBP1 Present: 3.5 kb PCR product No Insert: 1.0 kb PCR product Figure 8: Gel Electrophoresis of Control Vector Samples of pESC-LEU and pESC-URA. Amplification of control samples of both LEU and URA vectors revealed successful amplification of the desired region. However, a PCR test of one sample (10L) did not produce any product. This could be due to insufficient template addition, inadequate DNA extraction from yeast cells, or contamination within the template. Further investigation needs to be carried out in order to use PCR to analyze sample extracts. 10L  PCR confirmation of pESC-LEU/URA-MBP1 construct.  Introduction of MBP1 into S. cerevisiae mbp1 ∆ strain.  A Western Blot procedure to verify the expression of MBP1 in S. cerevisiae.  Observation of altered phenotypes due to the expression of MBP1, for example differences in the cell morphology and changes in the regulation of cell division.  Development of a simple protocol using yeast to obtain vector constructs with genes known to be toxic to bacteria. pESC-URA & LEU Vector Amp R Leu/Ura ori LaneEnzymes MBP1 Digested With Expected Fragments Fragments Observed in Gel? Before Transformation (Fig 5) Fragments Observed in Gel? After Transformation (Fig 6) 1Sal1/Xho12.5 kbYesNo 2BamH11.6 kb, 4.8 kbYesNo 3Xba15.1 kb, 800 bp, 500 bp YesNo 4HindIII2.5 kb, 3.9 kbYesNo PCR Transform into bacteria Figure 5: Restriction Digests of MBP1 Fragments to Confirm Sequence integrity. From the gel, all expected DNA fragments were accounted for, confirming DNA sequence integrity. Figure 7: Restriction Digest Results of MBP1 Fragment Ligations. Sixty-six bacterial colonies had pESC-Leu and Ura vector extracted and digested after the ligation of gene fragments (MF and MR) into the vector and transformation into the bacteria. These results indicate that full- length MBP1 is toxic to bacteria, while fragments of MBP1 are not. MF MR MF MR MF MR MFMR Leu MF Leu MR Ura MRUra MF Ura MR Ura MF Morphogenesis of C. albicans Figure 3: C. albicans Wild-type Virulence Assay. Varying concentrations of filamentous yeast with functional CPH1 and EFG1 were injected into mice for ∆, 1x107; x, 1x106; +, 1x105; o, 1x104.  Cases of hospital-acquired fungal infections, such as oropharyngeal candidiasis (OPC), continue to increase (Figure 1).  Recent studies of ICU fungal infections consistently find C. albicans to be the predominant yeast species isolated (Figure 2) (Shoham, et al., 2009).  Studies have identified CPH1 and EFG1 proteins as essential for morphogenesis of C. albicans. Understanding the role certain proteins play in morphogenesis may lead to new therapies (Hsiu- Jung, et al., 1997) (Figures 3 and 4).  There is evidence that MBP1 plays a role in the filamentous growth of C. albicans and is similar in sequence to the S. cerevisiae MBP1 gene.  We have found MBP1 to be toxic to bacteria, therefore traditional methods for obtaining the expression construct will not work.  A new protocol is being used where S. cerevisiae is transformed directly with the vector construct and cultured on selective media. Vector is then isolated and PCR amplified to confirm presence of MBP1.  Results of this work will contribute to our understanding of yeast morphogenesis and provide a protocol for studying genes that are toxic to bacteria. Figure 1:Illustration of Oropharyngeal Candidiasis Infection Fungal infections, such as OPC, have increased in recent years as a result of increasing cases of HIV/AIDS and antifungal resistant strains. Figure 2: Distribution of Isolated Yeast Species in ICU Fungal Infections. Recent studies have found that the predominant yeast species isolated in fungal infections to be C. albicans. Figure 4: C. albicans cph1/cph1, efg1/efg1 ∆ Mutant Virulence Assay. Varying concentrations of nonfilamentous C. albicans with nonfunctional CPH1 and EFG1 were injected into mice for ∆, 1x10 7 ; x, 1x10 6 ; +, 1x10 5 ; o, 1x10 4. Figure 6: Restriction Digests of Vector Constructs Containing MBP1 DNA from Figure 5. Notice how complete loss of restriction sites was observed, confirming the loss of sequence integrity in MBP1, suggesting it is toxic in bacteria. Table 1: Restriction Digests Setup of MBP1 Before and After Transformation into Bacteria. Shoham, et al., 2009 Hsiu-Jung, et al., 1997 DNA inserts are ligated into the vectors at one of two multiple cloning sites (MCS1 or MCS2). Then, expression of the insert DNA is driven by the respective promoter (PGAL1 or PGAL10) upstream of the insert DNA. With the addition of galactose to drive gene expression, the insert protein product should be produced.